The Meldofsky Firm has published a new briefing on the latest state of the ever-expanding class-action law suit against the manufacturers of the allegedly dangerous blood-thinning drug.
Beverly Hills, CA -- (SBWIRE) -- 09/14/2015 -- Xarelto is a blood thinning drug designed to help people with blood clotting disorders and other related conditions, and is approved by the FDA. Unlike other blood thinning drugs however, Xarelto has no known antidote, and users have been injured or even died as a result of intestinal and rectal bleeding, blood clots, uncontrolled bleeding events and even brain hemorrhages. The Meldofsky Firm has created a resource center, Xarelto Injury Lawsuits, to report on the development of the cases. Their latest report is their most dramatic yet, with more than 400 cases being added in just four weeks during August.
The Meldofsky Firm has reported that the Johnson & Johnson subsidiary, Janssen Pharmaceuticals and Bayer Healthcare Pharmaceutical are now being sued by 1,230 people after an increase of more than four hundred in just four weeks. This represents a near exponential rise, with just 500 cases reported in June and 800 in July.
The cases have been consolidated into the existing MDL 2592 case, which is now proceeding in the Court of Louisiana as a multi-district litigation case. This means that victims from everywhere in the United States can come forward together to obtain compensation. Meldofksy predict many more will come forward.
A spokesperson for Xarelto Injury Lawsuits explained, "This case identifies strongly as one on an upward spiral- with more cases added each month than in the month before. This month's case load increased by over one hundred on the previous month, which means more victims are becoming aware of the action and want to see themselves represented. Leading nationwide Xarelto lawyers Meldofsky Firm focuses on this form of representation, which is why we are raising awareness of the case: to help more victims find justice."
About Xarelto Injury Lawsuits
Xarelto Injury Lawsuits is an online resource center dedicated to keeping the public up to date with ongoing developments of the case against the manufacturers of the blood thinning drug Xarelto. The site is provided by The Meldofsky Firm, who focuses in defective device and dangerous drug injury cases, helping clients seek compensation following an injury or wrongful death as a result of Xarelto or other medication.
For more information please visit: http://xareltoinjurylawsuits.info/